These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15330257)

  • 21. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
    Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
    J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.
    Henneke P; Takeuchi O; Malley R; Lien E; Ingalls RR; Freeman MW; Mayadas T; Nizet V; Akira S; Kasper DL; Golenbock DT
    J Immunol; 2002 Oct; 169(7):3970-7. PubMed ID: 12244198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptors and their signaling mechanism in innate immunity.
    Kaisho T; Akira S
    Acta Odontol Scand; 2001 Jun; 59(3):124-30. PubMed ID: 11501880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors as key mediators in innate antifungal immunity.
    Roeder A; Kirschning CJ; Rupec RA; Schaller M; Weindl G; Korting HC
    Med Mycol; 2004 Dec; 42(6):485-98. PubMed ID: 15682636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR signalling and the function of dendritic cells.
    Hemmi H; Akira S
    Chem Immunol Allergy; 2005; 86():120-135. PubMed ID: 15976491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
    Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
    J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRAK-M is a negative regulator of Toll-like receptor signaling.
    Kobayashi K; Hernandez LD; Galán JE; Janeway CA; Medzhitov R; Flavell RA
    Cell; 2002 Jul; 110(2):191-202. PubMed ID: 12150927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
    Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
    Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
    Takeuchi O; Hoshino K; Akira S
    J Immunol; 2000 Nov; 165(10):5392-6. PubMed ID: 11067888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.
    Edelson BT; Unanue ER
    J Immunol; 2002 Oct; 169(7):3869-75. PubMed ID: 12244184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.
    Mancuso G; Midiri A; Beninati C; Biondo C; Galbo R; Akira S; Henneke P; Golenbock D; Teti G
    J Immunol; 2004 May; 172(10):6324-9. PubMed ID: 15128822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of microbial infection by Toll-like receptors.
    Kopp E; Medzhitov R
    Curr Opin Immunol; 2003 Aug; 15(4):396-401. PubMed ID: 12900270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes.
    Muzio M; Polentarutti N; Bosisio D; Prahladan MK; Mantovani A
    J Leukoc Biol; 2000 Apr; 67(4):450-6. PubMed ID: 10770275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors are temporally involved in host defense.
    Weiss DS; Raupach B; Takeda K; Akira S; Zychlinsky A
    J Immunol; 2004 Apr; 172(7):4463-9. PubMed ID: 15034062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.